The present invention relates to compositions (including medicaments and
nutritional products) for use in the prevention or treatment of
Inflammatory Bowel Disease. Such compositions comprise a therapeutically
effective amount of a soluble fibre derivable from fruit of the Musa spp.
The soluble fibre may in particular be derived from plantains or bananas.